Our Technology

Science

APstem Therapeutics scientists have discovered a new type of non-tumorigenic pluripotent stem cells from adult tissue which has demonstrated remarkable therapeutic effects in several tissue injury models. Our team has also developed a novel technology platform for in vitro expansion and directed differentiation of these pluripotent stem cells with simplicity and high efficiency.


Therapeutic Approach

The company is currently focusing on developing safe and effective regenerative therapies based on our novel pluripotent stem cells and technology platform. Our priority is to seek remedies for hard-to-heal injuries and degenerative diseases including, but not limited to, diabetic ulcers, liver diseases, and aging-associated diseases.